左舒必利注射液在中国健康受试者的药代动力学
发布时间:2018-10-23 19:55
【摘要】:目的研究左舒必利注射液在中国健康受试者单次及多次给药的药代动力学。方法用开放、随机、平行的试验设计。30名受试者,男女各半,分为3个剂量组,分别接受单次及多次肌内注射不同剂量左舒必利,采集不同时间的血样,用高效液相色谱-串联质谱法(HPLC/MS/MS)测定血浆中左舒必利的浓度。用DAS 3.0软件计算药代动力学参数。结果单次肌内注射25,50,75 mg左舒必利的主要药代动力学参数:cmax分别为(724.70±248.91),(949.60±234.80),(1619.00±366.80)μg·L-1;t1/2分别为(7.65±1.32),(7.58±0.89),(8.01±0.88)h,AUC0-t分别为(2874.17±1093.71),(4481.75±913.09),(7559.33±1428.87)μg·L-1·h。连续给药组t1/2为(7.41±0.79)h;AUC0-t为(4658.33±909.51)μg·L-1·h。结论中国健康受试者单次肌内注射给药左舒必利在25~75 mg内呈线性药代动力学特征,多次给药没有蓄积倾向,男、女间比较,差异无统计学意义。
[Abstract]:Objective to study the pharmacokinetics of left sulpiride injection in Chinese healthy volunteers. Methods A total of 30 subjects, half male and half male, were divided into three dose groups, and received intramuscular injection of different doses of levosulpiride at a single and multiple doses, and blood samples were collected at different times. The concentration of levosulpiride in plasma was determined by high performance liquid chromatography-tandem mass spectrometry (HPLC/MS/MS). The pharmacokinetic parameters were calculated by DAS 3.0 software. Results the main pharmacokinetic parameters of single intramuscular injection of left sulpiride at 75 mg were (724.70 卤248.91), () 949.60 卤234.80), (1619.00 卤366.80) 渭 g / L -1 / 2, respectively (7.65 卤1.32), (7.58 卤0.89), (8.01 卤0.88) h AUC0-t were (2874.17 卤1093.71), (4481.75 卤913.09), (7559.33 卤1428.87) 渭 g hL-1 respectively. T 1 / 2 was (7.41 卤0.79) h ~ (-1) AUC _ (0-t) and (4658.33 卤909.51) 渭 g 路L ~ (-1) h in continuous administration group. Conclusion the pharmacokinetic characteristics of single intramuscular injection of levosulpiride in Chinese healthy volunteers were linear within 2575 mg, and there was no accumulation tendency in multiple doses. There was no significant difference between male and female.
【作者单位】: 华中科技大学同济医学院附属协和医院临床药理研究室;
【分类号】:R969.1
本文编号:2290309
[Abstract]:Objective to study the pharmacokinetics of left sulpiride injection in Chinese healthy volunteers. Methods A total of 30 subjects, half male and half male, were divided into three dose groups, and received intramuscular injection of different doses of levosulpiride at a single and multiple doses, and blood samples were collected at different times. The concentration of levosulpiride in plasma was determined by high performance liquid chromatography-tandem mass spectrometry (HPLC/MS/MS). The pharmacokinetic parameters were calculated by DAS 3.0 software. Results the main pharmacokinetic parameters of single intramuscular injection of left sulpiride at 75 mg were (724.70 卤248.91), () 949.60 卤234.80), (1619.00 卤366.80) 渭 g / L -1 / 2, respectively (7.65 卤1.32), (7.58 卤0.89), (8.01 卤0.88) h AUC0-t were (2874.17 卤1093.71), (4481.75 卤913.09), (7559.33 卤1428.87) 渭 g hL-1 respectively. T 1 / 2 was (7.41 卤0.79) h ~ (-1) AUC _ (0-t) and (4658.33 卤909.51) 渭 g 路L ~ (-1) h in continuous administration group. Conclusion the pharmacokinetic characteristics of single intramuscular injection of levosulpiride in Chinese healthy volunteers were linear within 2575 mg, and there was no accumulation tendency in multiple doses. There was no significant difference between male and female.
【作者单位】: 华中科技大学同济医学院附属协和医院临床药理研究室;
【分类号】:R969.1
【相似文献】
相关期刊论文 前10条
1 江文娟;舒必利致低血钾1例报告[J];四川精神卫生;2004年04期
2 姬玉平;高彩凤;;简述舒必利的不良反应[J];四川精神卫生;2006年01期
3 王枢,江三多,张兆麟;舒必利的诱变效应初步研究[J];中国神经精神疾病杂志;1988年04期
4 雷招宝;;舒必利的不良反应 国内文献综述[J];药学情报通讯;1993年03期
5 宋海,冯西艳;舒必利的几种特殊不良反应[J];河北医药;1994年04期
6 关念红,张晋碚;舒必利停药致呕吐1例报告[J];新医学;1997年S1期
7 徐晓影;小剂量舒必利静滴致房颤1例[J];黑龙江医药科学;2001年03期
8 汪春运;;舒必利引起髋骨疼痛1例[J];临床心身疾病杂志;2007年01期
9 汪春运;;舒必利的作用谱[J];医药导报;2009年10期
10 杨明华;;口服舒必利致双下肢水肿1例[J];中国民康医学;2011年11期
相关会议论文 前3条
1 聂瑾芳;吴海龙;夏阿林;朱绍华;边英超;李淑芳;俞汝勤;;激发发射矩阵荧光结合二阶校正法用于尿液中舒必利的定量测定[A];第九届全国计算(机)化学学术会议论文摘要集[C];2007年
2 傅娟;;利培酮与舒必利对老年心电图的影响[A];2006年浙江省心电生理与起搏学术年会论文汇编[C];2006年
3 刘庆红;韩秀香;;氯氮平合并舒必利致胃粘膜出血一例[A];二零零四年度全国精神病专业第八次学术会议论文汇编[C];2004年
,本文编号:2290309
本文链接:https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/2290309.html
最近更新
教材专著